Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Experimental Therapeutics

Efficacy of Caspofungin Alone and in Combination with Voriconazole in a Guinea Pig Model of Invasive Aspergillosis

William R. Kirkpatrick, Sofia Perea, Brent J. Coco, Thomas F. Patterson
William R. Kirkpatrick
1Department of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: KIRKPATRICK@UTHSCSA.EDU
Sofia Perea
1Department of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brent J. Coco
1Department of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas F. Patterson
1Department of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229-3900
2Audie Murphy Division, South Texas Veterans Health Care System, San Antonio, Texas 78284
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.46.8.2564-2568.2002
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIG. 1.
    • Open in new tab
    • Download powerpoint
    FIG. 1.

    Cumulative mortality of 12 guinea pigs per treatment group treated with caspofungin (CAS), voriconazole (VRC), caspofungin plus voriconazole, or amphotericin B (AmB). Guinea pigs were challenged on the second day. Controls (□) received no antifungal therapy. Treatment of the guinea pigs with amphotericin B at 1.25 mg/kg/day (▵), caspofungin at 1 mg/kg/day (▪) or 2.5 mg/kg/day (▴), voriconazole at 5 mg/kg/day (⋄), caspofungin at 1 mg/kg/day plus voriconazole at 5 mg/kg/day (*), or caspofungin at 2.5 mg/kg/day plus voriconazole at 5 mg/kg/day (•) was initiated 24 h after challenge and was given daily for 5 days.

Tables

  • Figures
  • TABLE 1.

    Mean times of survival in temporarily immunosuppressed guinea pigs

    Group (dose [mg/kg/day])aMortality (no. of animals that died/total no. of animals tested) [% of total])Mean survival time (days)b
    Mean ± SERange
    Control12/12 (100)4.5 ± 0.293-6
    Caspofungin
        2.56/12 (50)c6.83 ± 0.37c5-8
        14/12 (33)c7.33 ± 0.31c5-8
    Caspofungin (2.5) + voriconazole (5)0/12 (0)c8c8
    Caspofungin (1) + voriconazole (5)0/12 (0)c8c8
    Voriconazole (5)0/12 (0)c8c8
    Amphotericin B3/12 (25)c7.08 ± 0.50c3-8
    • ↵ a There were 12 animals in each group.

    • ↵ b Time of survival from day of challenge with A. fumigatus.

    • ↵ c P < 0.0025 compared to controls.

  • TABLE 2.

    Results of semiquantitative cultures of organs from guinea pigs treated with antifungal agents beginning 24 h after challenge and killed 96 h after completion of therapy

    Group (dose [mg/kg/day])aColony count (mean ± SE log10CFU/g of tissue)
    LiverLungKidneyBrain
    Control3.32 ± 0.200.90 ± 0.223.11 ± 0.193.03 ± 0.23
    Caspofungin
        2.53.19 ± 0.450.42 ± 0.131.64 ± 0.31b2.97 ± 0.40
        11.93 ± 0.48b0.56 ± 0.231.42 ± 0.39b1.47 ± 0.45
    Caspofungin (2.5) + voriconazole (5)0.32 ± 0.20b0.11 ± 0.08b0.34 ± 0.19b0.13 ± 0.11b
    Caspofungin (1) + voriconazole (5)0.08 ± 0.04b0.05 ± 0.04b0.13 ± 0.11b0.19 ± 0.20b
    Voriconazole (5)0.35 ± 0.19b0.30 ± 0.070.58 ± 0.19b0.13 ± 0.09b
    Amphotericin B1.22 ± 0.37b0.38 ± 0.170.98 ± 0.32b0.87 ± 0.44b
    • ↵ a There were 12 animals in each group.

    • ↵ b P < 0.0025 compared to controls.

  • TABLE 3.

    Results of cultures of organs from temporarily immunosuppressed guinea pigs killed 96 h after completion of therapy

    Group (dose [mg/kg/day])aNo. of positive cultures/no. of guinea pig organs cultured
    LiverLungKidneyBrainAny organ
    Control12/1212/1212/1212/1212/12
    Caspofungin
        2.511/1210/1210/129/1212/12
        112/128/129/127/1212/12
    Caspofungin (2.5) + voriconazole (5)3/12b2/12b4/12b2/12b5/12b
    Caspofungin (1) + voriconazole (5)3/12b2/12b2/12b1/12b3/12b
    Voriconazole 56/128/128/123/12b12/12
    Amphotericin B8/126/128/124/12b11/12
    • ↵ a There were 12 animals in each group

    • ↵ b P < 0.0025 compared to controls.

PreviousNext
Back to top
Download PDF
Citation Tools
Efficacy of Caspofungin Alone and in Combination with Voriconazole in a Guinea Pig Model of Invasive Aspergillosis
William R. Kirkpatrick, Sofia Perea, Brent J. Coco, Thomas F. Patterson
Antimicrobial Agents and Chemotherapy Aug 2002, 46 (8) 2564-2568; DOI: 10.1128/AAC.46.8.2564-2568.2002

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Efficacy of Caspofungin Alone and in Combination with Voriconazole in a Guinea Pig Model of Invasive Aspergillosis
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Efficacy of Caspofungin Alone and in Combination with Voriconazole in a Guinea Pig Model of Invasive Aspergillosis
William R. Kirkpatrick, Sofia Perea, Brent J. Coco, Thomas F. Patterson
Antimicrobial Agents and Chemotherapy Aug 2002, 46 (8) 2564-2568; DOI: 10.1128/AAC.46.8.2564-2568.2002
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Anti-Bacterial Agents
antifungal agents
aspergillosis
peptides
Peptides, Cyclic
Pyrimidines
triazoles

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596